ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 176 filers reported holding ACORDA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $222,000 | -84.1% | 431,387 | -77.3% | 0.00% | -100.0% |
Q2 2020 | $1,398,000 | -46.2% | 1,903,004 | -31.7% | 0.00% | 0.0% |
Q1 2020 | $2,598,000 | -57.3% | 2,785,162 | -6.7% | 0.00% | -50.0% |
Q4 2019 | $6,091,000 | -32.7% | 2,985,489 | -5.3% | 0.00% | -50.0% |
Q3 2019 | $9,044,000 | -65.2% | 3,151,132 | -7.0% | 0.00% | -60.0% |
Q2 2019 | $25,982,000 | -37.7% | 3,387,612 | +7.9% | 0.01% | -41.2% |
Q1 2019 | $41,707,000 | -7.8% | 3,138,257 | +8.1% | 0.02% | -15.0% |
Q4 2018 | $45,229,000 | -20.4% | 2,903,093 | +0.4% | 0.02% | -9.1% |
Q3 2018 | $56,839,000 | -33.2% | 2,892,539 | -2.5% | 0.02% | -35.3% |
Q2 2018 | $85,113,000 | +15.3% | 2,965,704 | -5.0% | 0.03% | +9.7% |
Q1 2018 | $73,830,000 | +16.5% | 3,121,775 | +5.7% | 0.03% | +19.2% |
Q4 2017 | $63,381,000 | +0.9% | 2,954,691 | +11.2% | 0.03% | -3.7% |
Q3 2017 | $62,813,000 | +34.4% | 2,655,959 | +11.9% | 0.03% | +22.7% |
Q2 2017 | $46,745,000 | +21.5% | 2,372,868 | +29.6% | 0.02% | +22.2% |
Q1 2017 | $38,474,000 | +35.7% | 1,831,450 | +21.5% | 0.02% | +28.6% |
Q4 2016 | $28,342,000 | +1.0% | 1,507,562 | +12.2% | 0.01% | -6.7% |
Q3 2016 | $28,056,000 | -18.3% | 1,343,714 | -0.2% | 0.02% | -25.0% |
Q2 2016 | $34,344,000 | +10.7% | 1,346,545 | +14.8% | 0.02% | +5.3% |
Q1 2016 | $31,023,000 | -33.9% | 1,172,910 | +6.9% | 0.02% | -34.5% |
Q4 2015 | $46,939,000 | +64.7% | 1,097,219 | +2.1% | 0.03% | +52.6% |
Q3 2015 | $28,502,000 | -18.6% | 1,075,167 | +2.4% | 0.02% | -9.5% |
Q2 2015 | $35,008,000 | +12.3% | 1,050,339 | +12.1% | 0.02% | +5.0% |
Q1 2015 | $31,180,000 | +15.5% | 936,883 | +41.9% | 0.02% | +11.1% |
Q4 2014 | $26,987,000 | +20.1% | 660,329 | -0.4% | 0.02% | +12.5% |
Q3 2014 | $22,470,000 | -0.7% | 663,130 | -1.2% | 0.02% | 0.0% |
Q2 2014 | $22,620,000 | -11.3% | 671,026 | -0.2% | 0.02% | -15.8% |
Q1 2014 | $25,502,000 | +28.6% | 672,694 | -1.0% | 0.02% | +26.7% |
Q4 2013 | $19,832,000 | -14.6% | 679,193 | +0.3% | 0.02% | -25.0% |
Q3 2013 | $23,210,000 | +10.6% | 677,067 | +6.5% | 0.02% | 0.0% |
Q2 2013 | $20,977,000 | – | 635,853 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
Benin Management CORP | 11,714 | $11,000 | 0.01% |